Bernstein, Barry M.,Menon, Rajeev M.,Khatri, Amit,Mensing, Sven,Dutta, Sandeep,Cohen, Daniel E.,Podsadecki, Thomas J.,Brun, Scott C.,Awni, Walid M.,Dumas, Emily O.,Klein, Cheri E.
申请号:
AU2013201406
公开号:
AU2013201406A1
申请日:
2012.10.19
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
#$%^&*AU2013201406A120130509.pdf#####ABSTRACT OF THE DISCLOSURE The present invention features interferon-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to the subject effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), an inhibitor of cytochrome P450 (e.g., ritonavir), and ribavirin. 134